Free Trial
NASDAQ:DH

Definitive Healthcare Q3 2025 Earnings Report

Definitive Healthcare logo
$2.87 -0.21 (-6.82%)
Closing price 04:00 PM Eastern
Extended Trading
$2.98 +0.11 (+3.66%)
As of 05:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Definitive Healthcare EPS Results

Actual EPS
N/A
Consensus EPS
$0.06
Beat/Miss
N/A
One Year Ago EPS
N/A

Definitive Healthcare Revenue Results

Actual Revenue
N/A
Expected Revenue
$59.51 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Definitive Healthcare Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call Date
Thursday, November 6, 2025
Conference Call Time
5:00PM ET

Conference Call Resources

Definitive Healthcare Earnings Headlines

Analysts Set Definitive Healthcare Corp. (NASDAQ:DH) PT at $4.28
Buy UBER immediately
BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on some of the biggest winners of 2025.tc pixel
8 Best US Stocks Under $10 to Invest in
See More Definitive Healthcare Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Definitive Healthcare? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Definitive Healthcare and other key companies, straight to your email.

About Definitive Healthcare

Definitive Healthcare (NASDAQ:DH) (NASDAQ:DH) is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.

The company’s flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities. Users can access real-time insights into referral patterns, procedure volumes, affiliation networks and payer mix, as well as news alerts and forecasting tools. Definitive Healthcare also provides specialized modules for emerging therapeutic areas, such as oncology and medical device utilization, as well as workflow integrations with customer relationship management (CRM) and business intelligence (BI) systems.

Founded in 2011 by Brian Atwood, Definitive Healthcare has grown organically and through strategic acquisitions to broaden its content, geographies and analytical capabilities. The company completed its initial public offering in July 2021, marking a milestone in its expansion journey. It maintains headquarters in Nashville, Tennessee, and operates additional offices in North America and Europe to support a global customer base.

Leadership at Definitive Healthcare is anchored by founder and Chief Executive Officer Brian Atwood, who oversees the company’s product strategy, data operations and go-to-market initiatives. Under his direction, the management team has focused on fostering a data-driven culture, forging partnerships with key industry stakeholders and investing in advanced analytics to address the evolving needs of healthcare and life sciences organizations worldwide.

View Definitive Healthcare Profile

More Earnings Resources from MarketBeat